Skip to main content
Robert Gasser Jr., MD, Infectious Disease, Vienna, VA

RobertAnthonyGasserJr.MD

Infectious Disease Vienna, VA

Adjunct Professor, Medicine, Uniformed Services Hebert SOM

Dr. Gasser is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gasser's full profile

Already have an account?

  • Office

    9613 Chathams Ford Dr
    Vienna, VA 22182
    Phone+1 703-242-6259

Education & Training

  • National Capital Consortium
    National Capital ConsortiumFellowship, Infectious Disease, 1990 - 1993
  • Keesler Medical Center
    Keesler Medical CenterResidency, Internal Medicine, 1980 - 1982
  • Rochester General Hospital
    Rochester General HospitalInternship, Internal Medicine, 1978 - 1979
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1978

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2012 - 2026
  • NY State Medical License
    NY State Medical License 1979 - 2025
  • DC State Medical License
    DC State Medical License 1986 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease
  • American Society of Tropical Medicine and HygieneCertificate of Knowledge in Clinical Tropical Medicine and Travelers' Health
  • Wilderness Medical SocietyWilderness Life Support/Medical Professionals

Publications & Presentations

PubMed

Journal Articles

  • Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight ...  
    Michiko Asano, Akiko Sekikawa, Hyosung Kim, Robert A Gasser Jr, Darren Robertson, Marcella Petrone, Lutz Jermutus, Philip Ambery, Diabetes Obes Metab, 8/2021
  • Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study  
    Sands BE, Chen J, Feagan BG, Penney M, Rees WA, Danese S, Higgins PDR, Newbold P, Faggioni R, Patra K, Li J, Klekotka P, Morehouse C, Pulkstenis E, Drappa J, van der M..., Gastroenterology, 7/2017
  • Update on rapid diagnostic testing for malaria  
    Clinton K Murray, Robert A Gasser Jr, Alan J Magill, R Scott Miller, Clin Microbiol Rev, 1/2008
  • Join now to see all

Professional Memberships